cbdMD Statistics
Total Valuation
cbdMD has a market cap or net worth of $7.87 million. The enterprise value is $5.38 million.
Important Dates
The last earnings date was Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
cbdMD has 10.50 million shares outstanding. The number of shares has increased by 1,137.79% in one year.
| Current Share Class | 10.50M |
| Shares Outstanding | 10.50M |
| Shares Change (YoY) | +1,137.79% |
| Shares Change (QoQ) | +15.99% |
| Owned by Insiders (%) | 2.84% |
| Owned by Institutions (%) | 17.65% |
| Float | 10.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.38 |
| Forward PS | 0.66 |
| PB Ratio | 0.79 |
| P/TBV Ratio | 1.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.82 |
| Quick Ratio | 1.42 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.39% and return on invested capital (ROIC) is -29.08%.
| Return on Equity (ROE) | -53.39% |
| Return on Assets (ROA) | -14.43% |
| Return on Invested Capital (ROIC) | -29.08% |
| Return on Capital Employed (ROCE) | -28.84% |
| Weighted Average Cost of Capital (WACC) | 15.12% |
| Revenue Per Employee | $475,822 |
| Profits Per Employee | -$74,051 |
| Employee Count | 42 |
| Asset Turnover | 1.72 |
| Inventory Turnover | 2.48 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.43% in the last 52 weeks. The beta is 2.13, so cbdMD's price volatility has been higher than the market average.
| Beta (5Y) | 2.13 |
| 52-Week Price Change | -23.43% |
| 50-Day Moving Average | 0.79 |
| 200-Day Moving Average | 0.87 |
| Relative Strength Index (RSI) | 45.13 |
| Average Volume (20 Days) | 219,695 |
Short Selling Information
The latest short interest is 770,947, so 7.35% of the outstanding shares have been sold short.
| Short Interest | 770,947 |
| Short Previous Month | 322,354 |
| Short % of Shares Out | 7.35% |
| Short % of Float | 7.56% |
| Short Ratio (days to cover) | 0.23 |
Income Statement
In the last 12 months, cbdMD had revenue of $19.98 million and -$3.11 million in losses. Loss per share was -$0.36.
| Revenue | 19.98M |
| Gross Profit | 11.87M |
| Operating Income | -2.68M |
| Pretax Income | -2.66M |
| Net Income | -3.11M |
| EBITDA | -1.64M |
| EBIT | -2.68M |
| Loss Per Share | -$0.36 |
Full Income StatementBalance Sheet
The company has $2.64 million in cash and $415,132 in debt, with a net cash position of $2.22 million or $0.21 per share.
| Cash & Cash Equivalents | 2.64M |
| Total Debt | 415,132 |
| Net Cash | 2.22M |
| Net Cash Per Share | $0.21 |
| Equity (Book Value) | 9.28M |
| Book Value Per Share | 0.88 |
| Working Capital | 5.42M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.48 million and capital expenditures -$174,829, giving a free cash flow of -$2.65 million.
| Operating Cash Flow | -2.48M |
| Capital Expenditures | -174,829 |
| Depreciation & Amortization | 1.04M |
| Net Borrowing | n/a |
| Free Cash Flow | -2.65M |
| FCF Per Share | -$0.25 |
Full Cash Flow StatementMargins
Gross margin is 59.38%, with operating and profit margins of -13.40% and -13.29%.
| Gross Margin | 59.38% |
| Operating Margin | -13.40% |
| Pretax Margin | -13.29% |
| Profit Margin | -13.29% |
| EBITDA Margin | -8.20% |
| EBIT Margin | -13.40% |
| FCF Margin | n/a |
